4D Pharma PLC (DDDD)

41.95
-1.55(-3.56%)
  • Volume:
    2,167,470
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    41.40 - 43.10

DDDD Overview

Prev. Close
43.5
Day's Range
41.4-43.1
Revenue
490K
Open
43
52 wk Range
41.4-155.17
EPS
-0.44
Volume
2,167,470
Market Cap
75.64M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,994,155
P/E Ratio
-
Beta
3.23
1-Year Change
-65.61%
Shares Outstanding
180,300,966
Next Earnings Date
29 Mar 2022
What is your sentiment on 4D Pharma PLC?
or
Market is currently closed. Voting is open during market hours.

4D Pharma PLC Company Profile

Employees
92

4D pharma plc is a United Kingdom-based pharmaceutical company that focuses on developing Live Biotherapeutic Products (LBPs), which is a drug derived from the human microbiome. The Company's LBPs are biologics based on live organisms, namely single strains of bacteria. It has developed its research to build MicroRx, which is a discovery platform that is able to select those bacteria that have a therapeutic effect in specific diseases. It uses MicroRx to interrogate its library of bacterial isolates to identify LBPs. Its microbiome profiling platform, MicroDx, analyses the microbiome to aid the diagnosis and treatment of patients with its Live Biotherapeutics. Its MicroRx platform has generated a pipeline of development programs in therapeutic areas, including immuno-oncology, gastrointestinal (GI), respiratory, autoimmune and central nervous system (CNS) disease. It is conducting a phase I/II clinical study of MRx-4DP0004 in patients with poorly controlled asthma.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummarySellStrong SellStrong SellStrong SellStrong Sell
  • News rich q4 share price starting to recover!!
    0
    • whats going on today why price going up today?
      0
      • Bullish 100%
        1
        • Seems the bubble well and truly burst lol, expected a jump and got a puncture
          0
          • So much for the jump in share price after being listed on the NASDAQ
            3
            • Any news on the NASDAQ?
              1
              • Any more news on the stock appearing on the NASDAQ?
                0
                • Is this stock worth holding or sell now?
                  0
                  • Hold- new NASDAQ listing should help boost the shareprice. looking for 2.50 minimum for these shares
                    0
                  • Calum Burnsthank you, really appreciated
                    0
                • Supposedly hitting the NASDAQ sometime is Q1
                  0
                  • Is it worth holding on to or sell on?
                    0
                • Looking forward to see 4D get a boost when it appears on NASDAQ
                  0
                  • Any ideas when this is supposed to happen?
                    0
                  • When roughly?
                    0
                • Any news on this stock rising at any time?
                  0
                  • I heard 4d were up to something and something was going to be announced today. Rotten deal. and an extra $14 m will last them a few months I suppose. still no where near enough for phase 3 trials.
                    1
                    • Anyone know how they are going to raise more money? placing or Nasdaq IPO?
                      0
                      • Why the sudden drop?
                        1
                        • Blautix results were just above average. To be honest , Duncan said said he was "hopeful" on Blautix in his last interview so not a real surprise the SP has dropped
                          0
                        • Pro Fessorthank you 👍🏻
                          1
                      • I bought 4D on an impulse at the checkout without doing h/w. SP was reduced (yellow label). Would someone please tell me why I should hold and what to expect in the next few months. Is this a pure pharma play? I prefer to hold if there are prospects. Trading is hard work for an old man.
                        0
                        • Recommend you do your homework! Read the last RNS from company yesterday. (30/9/20). Clinical trail results expected first few days of October and has the potential to be the worlds first disease modifying therapy for IBS!!!! Game changer for this company IMO.
                          1
                        • Nav Akbar Thanks Nav. Good to know. BB chat sometimes provide an informed view of dry facts. Some facts are more equal than others.
                          0
                        • ***happened? 170p to 100p? "game changing" for the SP indeed !
                          0
                      • Is the rise over or will this go to £2, any thoughts?
                        1
                        • After consolidation, time will tell
                          1
                        • Addul, you are talking about  company which can effectively treat the root cause of cancer.   2 pounds will be nothing in years time.   With a  NASDAQ listing this year , the will be an IPO valuation north of 1 bill GBP min. IMO
                          0
                        • *there
                          0
                      • Outstanding news today, hence the rise. This will only go up!
                        1
                        • 4D will go up by £2 very soon. great news will come soon get ready to make bundle
                          2
                          • What gives you that idea/impression?
                            0
                        • Any thoughts on where this stock is heading?
                          0
                          • 40p
                            3
                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.